S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ZNTL Zentalis Pharmaceuticals Inc

11.06

0.00 (0.00%)

Pre Market

Last Updated: 06:00:00

Delayed by 15 minutes

Zentalis Pharmaceuticals EPS misses by $0.27

To read the full story on Seeking Alpha, click here.

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Zentalis Pharmaceuticals Inc News

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 1 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference
Tuesday 13 February 2024 (3 months ago) • GlobeNewswire Inc.

More Zentalis Pharmaceuticals Inc News Articles

Yuenglings Ice Cream (PK)

Virexit Technologies (PK)

Elite Pharmaceuticals (QB)

BlueFire Equipment (PK)

FuelCell Energy

Branded Legacy (PK)

Canopus Biopharma (PK)

Tonner One World (PK)

Global Developments (PK)

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions